The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation

Edoxaban is a selective direct factor Xa inhibitor. Edoxaban in a dose of 60 mg per day is an effective and safe option in the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation, including in combination therapy in patients after percutaneous coronary interve...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: O. O. Shakhmatova (Auteur)
Format: Livre
Publié: «REMEDIUM GROUP» Ltd., 2020-12-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible